SOD2 and cancer: Stratified analyses—in the larger Czech CRC group—of expression by tumor stage, grade, and TNM status, showed no significant differences after the BH correction, except for an association of a higher cancer stage and presence of lymph node metastasis with decreased SOD2 expression (PADJ = 0.004 and PADJ = 0.048, respectively).